December 22, 2022 02:00 PM ESTUpdated 02:45 PM
Pharma
FDA+
Coronavirus

Roche's Actem­ra wins ap­proval for hos­pi­tal­ized Covid pa­tients

Nicole DeFeudis

Editor

Roche up­grad­ed its emer­gency use au­tho­riza­tion for Actem­ra in cer­tain hos­pi­tal­ized Covid-19 pa­tients to a full FDA ap­proval, the com­pa­ny an­nounced …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

A service from the Financial Times